Treatment of localized dermatoses with intralesional betamethasome dipropionate.
Intralesional administration of betamethasone dipropionate, 5 mg/ml, was a safe and effective method of treating resistant localized lesions of patients with steroid-responsive dermatoses. Following a single injection, three-quarters of the patients had a good to excellent response which was maintained for the eight-week follow-up period.
D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged
D001623:Betamethasone